Pharmaceutical, biotech, medical device and other life sciences companies are under increasing pressure to succeed in a highly competitive and regulated marketplace. There is no room for error, especially when delivering life-changing products to customers. An integrated business platform for ERP, CRM and BI can optimize operations, support all phases of growth and deliver the very data needed to succeed.
New products in the Life Sciences industry fail to win a significant spot in the market at an alarming rate. And since the costs of bringing a product to market are extremely high – the risk of any missteps can be devastating. Therefore, it makes sense for biotech, pharma, and medical device companies to use every tool at their disposal to ensure they are as prepared as possible. Unfortunately, many companies overlook one of the most versatile tools available to them – their ERP solution.
If you are an early stage and rapidly growing Life Sciences organizations, download this free white paper to learn how Life Sciences ERP systems can help you:
Download the white paper now: Using ERP to Prepare for Commercialization.
If you’re like the millions of other mobile device users on the planet, you most likely download and utilize applications on your device on a daily basis. Maybe those apps help you stay organized, or they help you communicate faster with friends and family. What is quite probable is that you haven’t downloaded an app produced by a pharmaceutical company. Why is that? Pharmaceutical companies are still in the process of figuring out how to engage consumers through this platform. Mobile devices represent a significant opportunity for pharmaceutical companies – read on to learn more about how they can capitalize on them.
Mobile technologies have improved the speed at which life science companies innovate. The R&D process, the supply chain, and clinical tests can all run more efficiently and effectively thanks to the competitive advantages mobile technologies offer. That being said, mobile technologies are not without their challenges. Security and compliance are two examples of obstacles life science companies face. However, implementing a set of best practices regarding mobile technologies will enable life science firms to utilize them effectively and safely.
Life science companies stand on the cutting edge of technology. Their innovative discoveries save lives and make the world a better place to live. That doesn’t mean that they’re not vulnerable to the same digital threat landscape that affects other firms. This is especially true when it comes to mobile devices. Fortunately, life science companies need not be sitting ducks when comes to mobile threats. Read on to learn about how these businesses can handle mobile security challenges.
During this webinar we will discuss:
We hope you can join us for this free webinar!
Electronic Batch Records
Tuesday, March 8th, 2016
1:00pm – 2:00pm CST
Presented by: Merit Solutions and Ultra Consultants
The Food and Drug Administration was created in 1938. It has protected consumers from unsafe food, cosmetics, medicines, and medical devices. In the 21st century, the agency must now contend with the role of mobile technology in medicine. The FDA is still determining its regulatory scope in this field, but there are a few decisions it has made that impact life science companies.
In todays technology obsessed world, even the delivery of healthcare is dependent on software driven devices. Some are standalone, others are networked together. With the ever growing web of connectivity and the movement towards personal medical care, security issues predictably arise. Hacking has become so common place, we are no longer surprised when it happens. Losing your credit card information is bad enough but what if a wearable device was compromised by an anonymous cyber criminal? Remember, the motivation for someone to control another individuals pacemaker or insulin pump is irrelevant, the point is that if something can be hacked, someone will find away to do it. Hackers may use these devices as another means to troll for personal information.
In an ongoing effort to mitigate the risks patients are exposed to when using medical devices and pharmaceutical drugs, the FDA has recently enacted two regulations for companies in these industries:
Unique Device Identifier (UDI) regulations require most medical devices distributed in the United States to be documented and tracked.
The Drug Supply Chain Security Act (DSCSA) requires pharmaceutical companies to include product transaction information in an electronic or paper record every time ownership of the product or material is transferred.
Join us for our next webinar in our Mastering Compliance and Innovation Life Sciences Executive Series:
Product Serialization and Tracing
Wednesday March 4, 2015
12:00pm Eastern (9:00am Pacific)
Register now for the Product Serialization and Tracing Webinar!
Underestimating the scope and scale of these regulations could put your company at risk. In this session, we will discuss real-world applications of UDI and DSCSA using Microsoft Dynamics AX “ while diving into the fits, gaps, and solutions for complying with regulations and mitigating the risk associated with non-compliance.